Literature DB >> 29600008

Lung cancer recurrence epigenetic liquid biopsy.

Alicia Hulbert1, Ignacio Jusue-Torres2.   

Abstract

Entities:  

Year:  2018        PMID： 29600008      PMCID： PMC5863116          DOI： 10.21037/jtd.2017.11.124

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  17 in total

1.  Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  David S Ettinger; Douglas E Wood; Dara L Aisner; Wallace Akerley; Jessica Bauman; Lucian R Chirieac; Thomas A D'Amico; Malcolm M DeCamp; Thomas J Dilling; Michael Dobelbower; Robert C Doebele; Ramaswamy Govindan; Matthew A Gubens; Mark Hennon; Leora Horn; Ritsuko Komaki; Rudy P Lackner; Michael Lanuti; Ticiana A Leal; Leah J Leisch; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Karen Reckamp; Gregory J Riely; Steven E Schild; Theresa A Shapiro; James Stevenson; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2017-04       Impact factor: 11.908

Review 2.  New and emerging targeted treatments in advanced non-small-cell lung cancer.

Authors:  Fred R Hirsch; Kenichi Suda; Jacinta Wiens; Paul A Bunn
Journal:  Lancet       Date:  2016-09-01       Impact factor: 79.321

3.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

4.  Selection criteria for lung-cancer screening.

Authors:  Martin C Tammemägi; Hormuzd A Katki; William G Hocking; Timothy R Church; Neil Caporaso; Paul A Kvale; Anil K Chaturvedi; Gerard A Silvestri; Tom L Riley; John Commins; Christine D Berg
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

5.  Smoking cessation results in a clinical lung cancer screening program.

Authors:  Andrea K Borondy Kitts; Andrea B McKee; Shawn M Regis; Christoph Wald; Sebastian Flacke; Brady J McKee
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

6.  DNA methylation markers and early recurrence in stage I lung cancer.

Authors:  Malcolm V Brock; Craig M Hooker; Emi Ota-Machida; Yu Han; Mingzhou Guo; Stephen Ames; Sabine Glöckner; Steven Piantadosi; Edward Gabrielson; Genevieve Pridham; Kristen Pelosky; Steven A Belinsky; Stephen C Yang; Stephen B Baylin; James G Herman
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

7.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

8.  Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.

Authors:  S A Belinsky; K J Nikula; W A Palmisano; R Michels; G Saccomanno; E Gabrielson; S B Baylin; J G Herman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

9.  Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.

Authors:  David S Gierada; Paul Pinsky; Hrudaya Nath; Caroline Chiles; Fenghai Duan; Denise R Aberle
Journal:  J Natl Cancer Inst       Date:  2014-10-18       Impact factor: 13.506

10.  Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.

Authors:  Kate Brain; Ben Carter; Kate J Lifford; Olivia Burke; Anand Devaraj; David R Baldwin; Stephen Duffy; John K Field
Journal:  Thorax       Date:  2017-07-14       Impact factor: 9.139
View more
  1 in total

Review 1.  Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy.

Authors:  Chang Zeng; Emily Kunce Stroup; Zhou Zhang; Brian C-H Chiu; Wei Zhang
Journal:  Cancer Commun (Lond)       Date:  2019-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.